Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Prepaid Assets (2016 - 2025)

IGC Pharma (IGC) has disclosed Prepaid Assets for 15 consecutive years, with $130000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 34.34% to $130000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $130000.0, a 34.34% decrease, with the full-year FY2025 number at $342000.0, up 197.39% from a year prior.
  • Prepaid Assets was $130000.0 for Q3 2025 at IGC Pharma, down from $148000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.2 million in Q1 2021 to a low of $12000.0 in Q2 2021.
  • A 5-year average of $357000.0 and a median of $153500.0 in 2022 define the central range for Prepaid Assets.
  • Biggest YoY gain for Prepaid Assets was 1225.0% in 2022; the steepest drop was 94.75% in 2022.
  • IGC Pharma's Prepaid Assets stood at $12000.0 in 2021, then skyrocketed by 850.0% to $114000.0 in 2022, then tumbled by 57.89% to $48000.0 in 2023, then skyrocketed by 533.33% to $304000.0 in 2024, then plummeted by 57.24% to $130000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Prepaid Assets are $130000.0 (Q3 2025), $148000.0 (Q2 2025), and $342000.0 (Q1 2025).